S&P 500   3,849.51 (+0.21%)
DOW   30,793.41 (-0.66%)
QQQ   330.06 (+1.43%)
AAPL   144.76 (+4.09%)
MSFT   228.85 (+1.28%)
FB   279.51 (+1.83%)
GOOGL   1,920.02 (+1.45%)
AMZN   3,357.05 (+1.97%)
TSLA   863.87 (+2.04%)
NVDA   550.63 (+0.39%)
BABA   262.14 (+1.36%)
CGC   33.50 (-0.89%)
GE   11.01 (-0.90%)
MU   82.45 (+0.21%)
AMD   95.03 (+2.41%)
NIO   63.55 (+2.58%)
T   28.59 (-1.18%)
F   11.35 (-1.48%)
ACB   10.82 (+1.60%)
BA   201.04 (-2.33%)
DIS   171.55 (-0.71%)
NFLX   567.64 (+0.44%)
GILD   66.57 (-0.55%)
S&P 500   3,849.51 (+0.21%)
DOW   30,793.41 (-0.66%)
QQQ   330.06 (+1.43%)
AAPL   144.76 (+4.09%)
MSFT   228.85 (+1.28%)
FB   279.51 (+1.83%)
GOOGL   1,920.02 (+1.45%)
AMZN   3,357.05 (+1.97%)
TSLA   863.87 (+2.04%)
NVDA   550.63 (+0.39%)
BABA   262.14 (+1.36%)
CGC   33.50 (-0.89%)
GE   11.01 (-0.90%)
MU   82.45 (+0.21%)
AMD   95.03 (+2.41%)
NIO   63.55 (+2.58%)
T   28.59 (-1.18%)
F   11.35 (-1.48%)
ACB   10.82 (+1.60%)
BA   201.04 (-2.33%)
DIS   171.55 (-0.71%)
NFLX   567.64 (+0.44%)
GILD   66.57 (-0.55%)
S&P 500   3,849.51 (+0.21%)
DOW   30,793.41 (-0.66%)
QQQ   330.06 (+1.43%)
AAPL   144.76 (+4.09%)
MSFT   228.85 (+1.28%)
FB   279.51 (+1.83%)
GOOGL   1,920.02 (+1.45%)
AMZN   3,357.05 (+1.97%)
TSLA   863.87 (+2.04%)
NVDA   550.63 (+0.39%)
BABA   262.14 (+1.36%)
CGC   33.50 (-0.89%)
GE   11.01 (-0.90%)
MU   82.45 (+0.21%)
AMD   95.03 (+2.41%)
NIO   63.55 (+2.58%)
T   28.59 (-1.18%)
F   11.35 (-1.48%)
ACB   10.82 (+1.60%)
BA   201.04 (-2.33%)
DIS   171.55 (-0.71%)
NFLX   567.64 (+0.44%)
GILD   66.57 (-0.55%)
S&P 500   3,849.51 (+0.21%)
DOW   30,793.41 (-0.66%)
QQQ   330.06 (+1.43%)
AAPL   144.76 (+4.09%)
MSFT   228.85 (+1.28%)
FB   279.51 (+1.83%)
GOOGL   1,920.02 (+1.45%)
AMZN   3,357.05 (+1.97%)
TSLA   863.87 (+2.04%)
NVDA   550.63 (+0.39%)
BABA   262.14 (+1.36%)
CGC   33.50 (-0.89%)
GE   11.01 (-0.90%)
MU   82.45 (+0.21%)
AMD   95.03 (+2.41%)
NIO   63.55 (+2.58%)
T   28.59 (-1.18%)
F   11.35 (-1.48%)
ACB   10.82 (+1.60%)
BA   201.04 (-2.33%)
DIS   171.55 (-0.71%)
NFLX   567.64 (+0.44%)
GILD   66.57 (-0.55%)
Log in
NYSE:SMG

The Scotts Miracle-Gro Competitors

$232.94
+1.94 (+0.84 %)
(As of 01/25/2021 09:39 AM ET)
Add
Compare
Today's Range
$231.76
Now: $232.94
$233.39
50-Day Range
$173.54
MA: $203.16
$227.42
52-Week Range
$76.50
Now: $232.94
$231.67
Volume137 shs
Average Volume329,886 shs
Market Capitalization$12.97 billion
P/E Ratio34.21
Dividend Yield1.07%
Beta1.13

Competitors

The Scotts Miracle-Gro (NYSE:SMG) Vs. NTR, MOS, CF, ICL, AVD, and CLXT

Should you be buying SMG stock or one of its competitors? Companies in the industry of "agricultural chemicals" are considered alternatives and competitors to The Scotts Miracle-Gro, including Nutrien (NTR), The Mosaic (MOS), CF Industries (CF), ICL Group (ICL), American Vanguard (AVD), and Calyxt (CLXT).

Nutrien (NYSE:NTR) and The Scotts Miracle-Gro (NYSE:SMG) are both large-cap basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability.

Profitability

This table compares Nutrien and The Scotts Miracle-Gro's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Nutrien0.47%4.19%1.98%
The Scotts Miracle-Gro9.38%52.60%11.09%

Insider and Institutional Ownership

61.9% of Nutrien shares are owned by institutional investors. Comparatively, 63.1% of The Scotts Miracle-Gro shares are owned by institutional investors. 3.1% of Nutrien shares are owned by company insiders. Comparatively, 27.2% of The Scotts Miracle-Gro shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Nutrien and The Scotts Miracle-Gro's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nutrien$20.02 billion1.48$992 million$2.1724.05
The Scotts Miracle-Gro$4.13 billion3.14$387.40 million$7.2432.17

Nutrien has higher revenue and earnings than The Scotts Miracle-Gro. Nutrien is trading at a lower price-to-earnings ratio than The Scotts Miracle-Gro, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Nutrien has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Comparatively, The Scotts Miracle-Gro has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500.

Dividends

Nutrien pays an annual dividend of $1.80 per share and has a dividend yield of 3.4%. The Scotts Miracle-Gro pays an annual dividend of $2.48 per share and has a dividend yield of 1.1%. Nutrien pays out 82.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. The Scotts Miracle-Gro pays out 34.3% of its earnings in the form of a dividend. Nutrien has raised its dividend for 1 consecutive years and The Scotts Miracle-Gro has raised its dividend for 10 consecutive years.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Nutrien and The Scotts Miracle-Gro, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Nutrien151112.67
The Scotts Miracle-Gro01402.80

Nutrien presently has a consensus price target of $48.60, indicating a potential downside of 7.78%. The Scotts Miracle-Gro has a consensus price target of $203.80, indicating a potential downside of 11.77%. Given Nutrien's higher probable upside, research analysts clearly believe Nutrien is more favorable than The Scotts Miracle-Gro.

Summary

The Scotts Miracle-Gro beats Nutrien on 11 of the 18 factors compared between the two stocks.

The Scotts Miracle-Gro (NYSE:SMG) and The Mosaic (NYSE:MOS) are both large-cap basic materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Dividends

The Scotts Miracle-Gro pays an annual dividend of $2.48 per share and has a dividend yield of 1.1%. The Mosaic pays an annual dividend of $0.20 per share and has a dividend yield of 0.7%. The Scotts Miracle-Gro pays out 34.3% of its earnings in the form of a dividend. The Mosaic pays out 105.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. The Scotts Miracle-Gro has increased its dividend for 10 consecutive years. The Scotts Miracle-Gro is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Risk & Volatility

The Scotts Miracle-Gro has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500. Comparatively, The Mosaic has a beta of 1.81, suggesting that its stock price is 81% more volatile than the S&P 500.

Profitability

This table compares The Scotts Miracle-Gro and The Mosaic's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
The Scotts Miracle-Gro9.38%52.60%11.09%
The Mosaic-13.05%N/AN/A

Valuation and Earnings

This table compares The Scotts Miracle-Gro and The Mosaic's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Scotts Miracle-Gro$4.13 billion3.14$387.40 million$7.2432.17
The Mosaic$8.91 billion1.20$-1,067,400,000.00$0.19148.74

The Scotts Miracle-Gro has higher earnings, but lower revenue than The Mosaic. The Scotts Miracle-Gro is trading at a lower price-to-earnings ratio than The Mosaic, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

63.1% of The Scotts Miracle-Gro shares are held by institutional investors. Comparatively, 69.8% of The Mosaic shares are held by institutional investors. 27.2% of The Scotts Miracle-Gro shares are held by company insiders. Comparatively, 0.5% of The Mosaic shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and recommmendations for The Scotts Miracle-Gro and The Mosaic, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
The Scotts Miracle-Gro01402.80
The Mosaic1101102.45

The Scotts Miracle-Gro currently has a consensus price target of $203.80, indicating a potential downside of 11.77%. The Mosaic has a consensus price target of $22.3095, indicating a potential downside of 22.88%. Given The Scotts Miracle-Gro's stronger consensus rating and higher possible upside, equities analysts plainly believe The Scotts Miracle-Gro is more favorable than The Mosaic.

Summary

The Scotts Miracle-Gro beats The Mosaic on 13 of the 17 factors compared between the two stocks.

The Scotts Miracle-Gro (NYSE:SMG) and CF Industries (NYSE:CF) are both basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, dividends and risk.

Dividends

The Scotts Miracle-Gro pays an annual dividend of $2.48 per share and has a dividend yield of 1.1%. CF Industries pays an annual dividend of $1.20 per share and has a dividend yield of 2.8%. The Scotts Miracle-Gro pays out 34.3% of its earnings in the form of a dividend. CF Industries pays out 62.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. The Scotts Miracle-Gro has raised its dividend for 10 consecutive years.

Risk and Volatility

The Scotts Miracle-Gro has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Comparatively, CF Industries has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500.

Profitability

This table compares The Scotts Miracle-Gro and CF Industries' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
The Scotts Miracle-Gro9.38%52.60%11.09%
CF Industries7.00%5.14%2.34%

Valuation & Earnings

This table compares The Scotts Miracle-Gro and CF Industries' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Scotts Miracle-Gro$4.13 billion3.14$387.40 million$7.2432.17
CF Industries$4.59 billion2.00$493 million$1.9322.21

CF Industries has higher revenue and earnings than The Scotts Miracle-Gro. CF Industries is trading at a lower price-to-earnings ratio than The Scotts Miracle-Gro, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

63.1% of The Scotts Miracle-Gro shares are owned by institutional investors. Comparatively, 91.0% of CF Industries shares are owned by institutional investors. 27.2% of The Scotts Miracle-Gro shares are owned by company insiders. Comparatively, 2.0% of CF Industries shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings for The Scotts Miracle-Gro and CF Industries, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
The Scotts Miracle-Gro01402.80
CF Industries19902.42

The Scotts Miracle-Gro currently has a consensus target price of $203.80, indicating a potential downside of 11.77%. CF Industries has a consensus target price of $40.9333, indicating a potential downside of 5.68%. Given CF Industries' higher possible upside, analysts plainly believe CF Industries is more favorable than The Scotts Miracle-Gro.

Summary

The Scotts Miracle-Gro beats CF Industries on 10 of the 17 factors compared between the two stocks.

The Scotts Miracle-Gro (NYSE:SMG) and ICL Group (NYSE:ICL) are both basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, dividends and risk.

Dividends

The Scotts Miracle-Gro pays an annual dividend of $2.48 per share and has a dividend yield of 1.1%. ICL Group pays an annual dividend of $0.09 per share and has a dividend yield of 1.7%. The Scotts Miracle-Gro pays out 34.3% of its earnings in the form of a dividend. ICL Group pays out 24.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. The Scotts Miracle-Gro has raised its dividend for 10 consecutive years. ICL Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Risk and Volatility

The Scotts Miracle-Gro has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Comparatively, ICL Group has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500.

Profitability

This table compares The Scotts Miracle-Gro and ICL Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
The Scotts Miracle-Gro9.38%52.60%11.09%
ICL Group-0.12%5.99%2.56%

Valuation & Earnings

This table compares The Scotts Miracle-Gro and ICL Group's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Scotts Miracle-Gro$4.13 billion3.14$387.40 million$7.2432.17
ICL Group$5.27 billion1.32$475 million$0.3714.65

ICL Group has higher revenue and earnings than The Scotts Miracle-Gro. ICL Group is trading at a lower price-to-earnings ratio than The Scotts Miracle-Gro, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

63.1% of The Scotts Miracle-Gro shares are owned by institutional investors. Comparatively, 7.4% of ICL Group shares are owned by institutional investors. 27.2% of The Scotts Miracle-Gro shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings for The Scotts Miracle-Gro and ICL Group, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
The Scotts Miracle-Gro01402.80
ICL Group02002.00

The Scotts Miracle-Gro currently has a consensus target price of $203.80, indicating a potential downside of 11.77%. ICL Group has a consensus target price of $5.25, indicating a potential downside of 3.14%. Given ICL Group's higher possible upside, analysts plainly believe ICL Group is more favorable than The Scotts Miracle-Gro.

Summary

The Scotts Miracle-Gro beats ICL Group on 11 of the 17 factors compared between the two stocks.

The Scotts Miracle-Gro (NYSE:SMG) and American Vanguard (NYSE:AVD) are both basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, dividends and risk.

Dividends

The Scotts Miracle-Gro pays an annual dividend of $2.48 per share and has a dividend yield of 1.1%. American Vanguard pays an annual dividend of $0.08 per share and has a dividend yield of 0.4%. The Scotts Miracle-Gro pays out 34.3% of its earnings in the form of a dividend. American Vanguard pays out 17.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. The Scotts Miracle-Gro has raised its dividend for 10 consecutive years and American Vanguard has raised its dividend for 1 consecutive years. The Scotts Miracle-Gro is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Risk and Volatility

The Scotts Miracle-Gro has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Comparatively, American Vanguard has a beta of 1.02, indicating that its share price is 2% more volatile than the S&P 500.

Profitability

This table compares The Scotts Miracle-Gro and American Vanguard's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
The Scotts Miracle-Gro9.38%52.60%11.09%
American Vanguard2.40%3.16%1.61%

Valuation & Earnings

This table compares The Scotts Miracle-Gro and American Vanguard's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Scotts Miracle-Gro$4.13 billion3.14$387.40 million$7.2432.17
American Vanguard$468.19 million1.17$13.60 million$0.4639.30

The Scotts Miracle-Gro has higher revenue and earnings than American Vanguard. The Scotts Miracle-Gro is trading at a lower price-to-earnings ratio than American Vanguard, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

63.1% of The Scotts Miracle-Gro shares are owned by institutional investors. Comparatively, 76.5% of American Vanguard shares are owned by institutional investors. 27.2% of The Scotts Miracle-Gro shares are owned by company insiders. Comparatively, 5.3% of American Vanguard shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings for The Scotts Miracle-Gro and American Vanguard, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
The Scotts Miracle-Gro01402.80
American Vanguard0000N/A

The Scotts Miracle-Gro currently has a consensus target price of $203.80, indicating a potential downside of 11.77%. Given The Scotts Miracle-Gro's higher possible upside, equities research analysts plainly believe The Scotts Miracle-Gro is more favorable than American Vanguard.

Summary

The Scotts Miracle-Gro beats American Vanguard on 13 of the 16 factors compared between the two stocks.

The Scotts Miracle-Gro (NYSE:SMG) and Calyxt (NASDAQ:CLXT) are both basic materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability and earnings.

Institutional & Insider Ownership

63.1% of The Scotts Miracle-Gro shares are held by institutional investors. Comparatively, 23.8% of Calyxt shares are held by institutional investors. 27.2% of The Scotts Miracle-Gro shares are held by company insiders. Comparatively, 2.3% of Calyxt shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Risk & Volatility

The Scotts Miracle-Gro has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Comparatively, Calyxt has a beta of 2.36, indicating that its share price is 136% more volatile than the S&P 500.

Valuation and Earnings

This table compares The Scotts Miracle-Gro and Calyxt's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Scotts Miracle-Gro$4.13 billion3.14$387.40 million$7.2432.17
Calyxt$7.30 million46.56$-39,610,000.00($1.21)-7.58

The Scotts Miracle-Gro has higher revenue and earnings than Calyxt. Calyxt is trading at a lower price-to-earnings ratio than The Scotts Miracle-Gro, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent recommendations for The Scotts Miracle-Gro and Calyxt, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
The Scotts Miracle-Gro01402.80
Calyxt05302.38

The Scotts Miracle-Gro currently has a consensus price target of $203.80, indicating a potential downside of 11.77%. Calyxt has a consensus price target of $7.8571, indicating a potential downside of 14.32%. Given The Scotts Miracle-Gro's stronger consensus rating and higher possible upside, equities analysts clearly believe The Scotts Miracle-Gro is more favorable than Calyxt.

Profitability

This table compares The Scotts Miracle-Gro and Calyxt's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
The Scotts Miracle-Gro9.38%52.60%11.09%
Calyxt-318.57%-89.86%-58.95%

Summary

The Scotts Miracle-Gro beats Calyxt on 12 of the 14 factors compared between the two stocks.


The Scotts Miracle-Gro Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Nutrien logo
NTR
Nutrien
1.7$52.19+1.0%$29.99 billion$20.02 billion307.00
The Mosaic logo
MOS
The Mosaic
1.7$28.26+0.2%$10.74 billion$8.91 billion-9.85Analyst Upgrade
News Coverage
Gap Down
CF Industries logo
CF
CF Industries
2.1$42.86+1.3%$9.28 billion$4.59 billion32.47
ICL Group logo
ICL
ICL Group
1.7$5.42+0.4%$6.94 billion$5.27 billion14.65
American Vanguard logo
AVD
American Vanguard
0.9$18.08+2.0%$558.51 million$468.19 million48.87
Calyxt logo
CLXT
Calyxt
0.9$9.17+13.7%$293.18 million$7.30 million-6.89Analyst Upgrade
Analyst Revision
Gap Down
Marrone Bio Innovations logo
MBII
Marrone Bio Innovations
1.1$1.61+1.2%$242.63 million$29.37 million-8.47
CVR Partners logo
UAN
CVR Partners
0.9$15.95+2.7%$177.03 million$404.18 million-1.70
Evogene logo
EVGN
Evogene
1.3$6.64+7.7%$157.85 million$750,000.00-8.20Gap Down
CGA
China Green Agriculture
0.8$6.41+8.0%$40.70 million$249.24 million-0.24
SenesTech logo
SNES
SenesTech
1.3$2.38+8.0%$9.85 million$140,000.00-0.31
This page was last updated on 1/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.